Boston, United States
Emulate, Inc., founded in 2014, is revolutionizing the biotechnology sector with its pioneering Organ-on-a-Chip technology. The company's slogan, "Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biology and disease," encapsulates its mission to enhance the field of human health research.
By enabling researchers to replicate human tissue function and disease biology, Emulate is not only reducing reliance on animal testing but also speeding up drug development and lowering associated costs. The company's platforms are crucial tools for leading pharmaceutical, biotech, and academic teams aiming to produce human-relevant data, thus advancing safer and more effective therapies.
Headquartered in the United States, Emulate recently secured a $47.07M Series F investment, with Qiming Venture Partners as a notable investor, underscoring strong confidence in its innovative potential within the Biotechnology, Health Care, and Life Sciences industries.
